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Abstract
In this study, we first aimed at determining whether human
articular chondrocytes (HAC) proliferate in aggregates in
the presence of strong chondrocyte mitogens. We then
investigated if the aggregated cells have an enhanced
chondrogenic capacity as compared to cells cultured in
monolayer. HAC from four donors were cultured in tissue
culture dishes either untreated or coated with 1% agarose
in the presence of TGFβ-1, FGF-2 and PDGF-BB.
Proliferation and stage of differentiation were assessed by
measuring respectively DNA contents and type II collagen
mRNA. Expanded cells were induced to differentiate in
pellets or in Hyaff®-11 meshes and the formed tissues were
analysed biochemically for glycosaminoglycans (GAG) and
DNA, and histologically by Safranin O staining. The
amount of DNA in aggregate cultures increased
significantly from day 2 to day 6 (by 3.2-fold), but did not
further increase with additional culture time. Expression
of type II collagen mRNA was about two orders of
magnitude higher in aggregated HAC as compared to
monolayer expanded cells. Pellets generated by aggregated
HAC were generally more intensely stained for GAG than
those generated by monolayer-expanded cells. Scaffolds
seeded with aggregates accumulated more GAG (1.3-fold)
than scaffolds seeded with monolayer expanded HAC. In
conclusion, this study showed that HAC culture in
aggregates does not support a relevant degree of expansion.
However, aggregation of expanded HAC prior to loading
into a porous scaffold enhances the quality of the resulting
tissues and could thus be introduced as an intermediate
culture phase in the manufacture of engineered cartilage
grafts.
Keywords: articular chondrocytes, chondrogenesis, cell
differentiation, cartilage tissue engineering.
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Introduction
Cartilage repair techniques based on the use of autologous
chondrocytes, either directly injected into the defect or
further processed to engineer cartilaginous grafts, typically
rely on the ex vivo expansion of the limited number of
cells that can be obtained from a small biopsy. However,
chondrocyte expansion is intrinsically associated with the
well-known problem of cell de-differentiation (Benya and
Shaffer, 1982; Binette et al., 1998), and the re-
differentiation capacity of expanded cells, especially if
of human origin, is rather limited (Bonaventure et al.,
1994). In order to enhance the chondrogenic ability of
expanded chondrocytes, several strategies have been
proposed with various degrees of success, including
medium supplementation with specific growth factors
(Jakob et al., 2001; Barbero et al., 2003; Malpeli et al.,
2004), cell growth on microcarrier beads (Malda et al.,
2003) or on collagen type II-coated substrates (Barbero
et al., 2006).
Alternatively, considering that chondrocyte de-
differentiation is linked to the cytoskeletal changes
induced by cell spreading on a culture substrate (Mayne
et al., 1976), chondrocytes could be expanded under
conditions inhibiting cell adhesion. The proof of principle
of this approach was provided by chondrocyte expansion
in alginate beads (Lee et al., 2003); however, repeated
passaging in alginate was necessary to obtain relevant
numbers of cells. A more simple implementation of the
same principle would be offered by chondrocyte culture
on agarose coated dishes. Using this culture model, human
articular chondrocytes (HAC) have been shown to form
three-dimensional (3D) aggregates, also referred to as
clusters or spheroids, and to maintain the expression of
cartilage specific proteins (Kolettas et al., 1995; Anderer
and Libera, 2002). However, little or no proliferation was
reported (Kolettas et al., 1995).
In this study, we first aimed at determining whether in
the presence of a combination of strong chondrocyte
mitogens it is possible to achieve HAC proliferation in
aggregate cultures. We then investigated whether the
aggregated cells have an enhanced chondrogenic capacity
as compared to cells cultured using traditional monolayer
techniques. A partial expansion in monolayer prior to the
culture phase in aggregate was introduced to permit more
extensive cell proliferation while minimizing chondrocyte
de-differentiation (Fig. 1). The chondrogenic ability of
the expanded cells was then tested in a standard pellet
culture model or using a porous 3D scaffold, that would
permit the generation of relatively large cartilage grafts
with a limited amount of chondrocyte aggregates.
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Materials and Methods
Cartilage collection and cell isolation
Human articular cartilage samples (approximately 200 mg
tissue) were collected after informed consent and in
accordance with the local Ethical Commission from the
knee joints of 4 individuals with no known clinical history
of joint disorders (donor 1: female, 51 years; donor 2:
female, 67 years; donor 3: male, 71 years, donor 4: male,
18 years). Chondrocytes were isolated using 0.15% type
II collagenase (Bioconcept Worthington, Allschwill,
Switzerland) for 22 hours and resuspended in Dulbecco’s
modified Eagle’s medium (DMEM) containing, 4.5 mg/
ml D-glucose, 0.1 mM nonessential amino acids, 1 mM
sodium pyruvate, 100 mM HEPES buffer, 100 U/ml
penicillin, 100 μg/ml streptomycin, 0.29 mg/ml L-
glutamine (complete medium) and 10% foetal bovine
serum (FBS).
Cell expansion and aggregation
Human articular chondrocytes (HAC) were plated on tissue
culture dishes at 104 cells/cm2 in 10% FBS supplemented
complete medium with the addition of 5 ng/ml of Fibroblast
Growth Factor-2, 10 ng/ml of Platelet-Derived Growth
Factor-bb and 1 ng/ml of Transforming Growth Factor-β1
(all from R&D Systems, Minneapolis, MN, USA),
previously reported to be potent mitogens for HAC (Jakob
et al., 2001), and cultured until they reached about 80%
confluence (7-10 days; Phase 1, see Fig.1). HAC were
then detached using 0.3% type II collagenase and 0.05%
trypsin/0.53mM EDTA (Gibco; Invitrogen, Basel,
Switzerland) and replated at 5x103 cells/cm2 in culture
dishes either untreated or coated with 1.0% agarose
(Sigma-Aldrich, Hamburg, Germany), in order to support
respectively cell growth in monolayers or the formation
of aggregates (up to 14 days; Phase 2, see Fig.1). Culture
medium during Phase 2 was also supplemented with the 3
growth factors used for Phase 1. At each feeding,
aggregates collected in the spent medium were resuspended
in fresh medium and returned to the culture dish. Cells
cultured in monolayer or in aggregates were either
processed for gene expression analysis or induced to re-
differentiate using the two models described below (Phase
3, see Fig. 1).
Cell redifferentiation
Pellet culture. For this differentiation assay, cells from
3 donors (donor 1, donor 2 and donor 3) were used.
Monolayer- or aggregate-cultured cells were transferred
into polypropylene conical tubes (respectively 5x105 cells/
pellet and 1 to 4 aggregates/pellet, depending on their size)
in the presence of complete medium supplemented with
insulin, transferrin and selenous acid (ITS+1, Sigma
Chemical, St. Louis, MO, USA), 0.1 mM ascorbic acid 2-
phosphate, 1.25 mg/ml human serum albumin, 10-7 M
dexamethasone and 10 ng/ml Transforming Growth
Factor-β1 to establish pellet cultures, as previously
described (Barbero et al., 2004). Pellets were placed onto
a 3D orbital shaker (Bioblock Scientific, Frenkendorf,
Switzerland) at 30 rpm and cultured for 2 weeks in 0.5 ml
of medium/pellet, with medium changes twice per week.
Subsequently pellets were processed for histological or
biochemical analysis.
3D culture within scaffolds. For this differentiation
assay, cells from 2 donors (donor 3 and donor 4) were
used. Monolayer- or aggregate-cultured cells were seeded
on Hyaff®-11 non-woven meshes (8 mm diameter, 2 mm
thick discs; Fidia Advanced Biopolymers, Abano Terme,
Italy) by direct perfusion through the scaffold pores. 4 or
8 millions of HAC as single cells or as aggregates were
Figure 1. Experimental design. Human articular chondrocytes (HAC) isolated from cartilage biopsies (N = 4)
were expanded for one passage in monolayer (Phase 1) and then cultured in dishes either uncoated or coated with
agarose to generate monolayer cells or form aggregates, respectively (Phase 2). At the end of Phase 2, aggregates
or monolayer expanded chondrocytes were induced to redifferentiate in a pellet culture model or within Hyaff®-11
non-woven meshes (Phase 3).
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perfused in alternate directions through each mesh in 4 ml
of culture medium at a superficial velocity of 3 ml/min for
24 hours (Wendt et al., 2003). The number of cells in
aggregates was estimated by measuring the DNA contents
of aliquots of cell-cluster suspension on the day before the
seeding. After perfusion seeding the resulting cell-scaffold
constructs were processed histologically to examine the
distribution of the cells thought the scaffold, by quantifying
the DNA content to assess the cell seeding efficiency, or
transferred on agarose coated dishes and cultured in
complete medium supplemented with 10% FBS, 0.1 mM
ascorbic acid 2-phosphate, 10 mg/ml Insulin and 10 ng/ml
Transforming Growth Factor-b3 for 4 weeks with medium
changes twice per week (Candrian et al., 2008).
Analyses of cells and tissues
Real-time quantitative RT-PCR assays. Total RNA
of cells after Phase 2 (see Fig. 1) was extracted using Trizol
(Life Technologies, Basel, Switzerland) and the standard
single-step acid-phenol guanidinium method. RNA was
treated with DNAseI using the DNA-freeTM Kit (Ambion/
Applied Biosystems, Foster City, CA, USA) and quantified
spectrometrically. cDNA was generated from 3 μg of RNA
by using 500 μg/ml random hexamers (Catalys AG,
Wallisellen, Switzerland) and 1 μl of 50 U/ml StratascriptTM
reverse transcriptase (Stratagene, Amsterdam, the
Netherlands), in the presence of dNTPs. Real-time RT-PCR
reactions were performed and monitored using the ABI
Prism 7700 Sequence Detection System (Perkin-Elmer/
Applied Biosystems, Rotkreuz, Switzerland). After an
initial denaturation at 95°C for 10 min, the cDNA products
were amplified with 45 PCR cycles, consisting of a
denaturation step at 95°C for 15 s and an extension step at
60°C for 1 min. The following primers and probes were
used at the concentrations indicated in parenthesis:
CII-forward primer:
5’-GGCAATAGCAGGTTCACGTACA (900 nM),
CII-reverse primer:
5’-CGATAACAGTCTTGCCCCACTT (900 nM),
CII-probe:
5’-CCGGTATGTTTCGTGCAGCCATCCT (200 nM);
18-S-forward primer:
5’-CGGCTACCACATCCAAGGAA (26 nM),
18-S-reverse primer:
5’-GCTGGAATTACCGCGGCT (26 nM),
18-S-probe:
5’-TGCTGGCACCAGACTTGCCCTC (50 nM).
For each sample, the threshold cycle (Ct) value was
determined as the cycle number at which the fluorescence
intensity reached 0.05. For each cDNA sample, the value
of 18-S was subtracted from the Ct value of the target gene,
to derive μCt. The level of expression of type II collagen
was calculated as 2μCt. Each sample was assessed at least
in duplicate.
DNA  and Glycosaminoglycan (GAG)
quantification. Aggregates generated at different times
during Phase 2 (i.e., at day 0, 2, 4, 6, 8 and 14), pellets
cultured for 2 weeks and cell-scaffold constructs
immediately after seeding or 4 weeks’s culture were
digested with protease K (0.5 ml of 1 mg/ml protease K in
50 mM Tris with 1 mM EDTA, 1 mM iodoacetamide, and
10 μg/ml pepstatin-A for 15 hours at 56°C) as previously
described (Hollander et al., 1994). The DNA amount was
measured spectrofluorometrically using the CyQUANT®
Kit (Molecular Probes, Eugene, OR, USA) following the
kit’s instruction. Briefly, CyQUANT® NF dye reagent was
applied to cell lysets aliquoted in a 96-well plate (3 wells
per sample). After a 30 minute incubation, fluorescence
was measured (excitation: 485 nm; emission: 530 nm) and
compared to standard curve prepared simultaneously using
calf thymus DNA.
Glycosaminoglycan (GAG) contents of pellets and
constructs were measured spectrophotometrically using
the dimethylmethylene blue (DMMB) assay (Farndale et
al., 1986). Briefly, DMMB solution was applied to cell
lysets aliquoted in a 96-well plate (4 wells per sample).
Absorbance was measured at 525 nm and compared to
curve prepared simultaneously using chondroitin sulphate
(Sigma-Aldrich). GAG contents of pellets and cell-scaffold
constructs are reported as μg GAG / μg DNA.
Histological analysis. Cell pellets and cell-scaffold
constructs were fixed in 4% formalin, embedded in
paraffin, cross-sectioned (5 μm thick) and stained with
Safranin O for sulphated GAG.
Statistical Analysis. All values are presented as mean
± standard deviation of measurements from 3 independent
experiments (i.e., with cells from the 3 different donors).
Differences among experimental groups were assessed by
Mann Whitney tests, and considered statistically significant
with P < 0.05.
Results and Discussion
Proliferation and differentiation stage of HAC
cultured in monolayer or in aggregates
In the first set of experiments HAC were cultured in
monolayer or on agarose coated dish in the presence of a
growth factor combination (namely TGFβ-1, FGF-2 and
PDGF-BB) known to strongly enhance the proliferation
rate of monolayer cultured chondrocytes (Barbero et al.,
2003). HAC cultured on agarose coated surfaces remained
non-adherent and formed aggregates growing in size with
time, in agreement with previous studies (Archer et al.,
1990; Izumi et al., 2000; Kolettas et al., 1995; Anderer
and Libera, 2002). In particular, during the first 6 days of
aggregate culture cells generated rather uniformly sized
aggregates (size 15-70 μm), which during the second week
of expansion tended to fuse together and form larger
aggregates, with highly variable sizes (Fig. 2A). The
amount of DNA in aggregate cultures increased
significantly from day 2 to day 6 (by 3.2-fold), but did not
further increase with additional culture time (Fig. 2B).
During the first 6 days of culture in Phase 2, as compared
to monolayer-expanded cells, the proliferation rate of HAC
cultured in aggregates was 5.4-fold lower (Fig. 2C),
whereas the expression of collagen type II mRNA was
about two orders of magnitude higher (Fig. 2D), and only
about 5-fold lower than in native cartilage tissues. Our
findings are in general agreement with those by Kolettas
et al. (1995), reporting that chondrocytes in aggregates
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Figure 2. Morphology, proliferation capacity and phenotype of human articular chondrocytes (HAC)
expanded in monolayer or aggregates. (A) Representative pictures of monolayer (I) and aggregates (II, III
and IV)  formed by HAC at day 3 (II), 6 (I and III), or 14 (IV) of culture in Phase 2. Bar = 100 μm. (B) DNA
quantification of HAC cultured as aggregates for different time points. * = p<0.05 from the previous time point.
(C) Proliferation rates of HAC expanded as monolayer or aggregates. * = p<0.05 from monolayer. (D) Real time
RT-PCR analysis of the mRNA expression of collagen type II by HAC after 6 days of culture in Phase 2. The
dashed line indicates the mean collagen type II mRNA expression level of corresponding native tissues. * =
p<0.05 from monolayer.
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expressed higher amounts of collagen type II both at
mRNA and protein level than those cultured in monolayer.
The limited proliferative activity of chondrocytes in
aggregates, despite the medium supplementation with
potent mitogens, is also consistent with previous reports
on disc cells, which were found to weakly respond to the
mitogenic factor PDGF when cultured in alginate (Gruber
and Hanley, 2000).
Since aggregate culture did not result in relevant
proliferation (i.e., only about 1 doubling in the first 6 days),
for subsequent experiments of tissue formation (Phase 3)
we compared cells cultured as monolayer or as aggregates
in Phase 2 only for 3 days. Thus, for these experiments
aggregation in Phase 2 was not used to further expand
cells, but only to pre-condition cells for subsequent
chondrogenesis assays.
Redifferentiation of HAC cultured in monolayer or
in aggregates
Pellet culture. HAC from three donors cultured in
monolayer or aggregates for 3 days in Phase 2 were
transferred into a pellet culture model and induced to
redifferentiate in the presence of chondrogenic stimuli.
After 2 weeks’ culture, pellets generated by aggregated
HAC were generally more intensely stained for GAG than
those generated by monolayer-expanded cells isolated from
the same donors, although variable levels of GAG staining
intensity were observed in pellets derived by different
aggregates from the same primary culture (Fig 3A). Thus,
no statistically significant difference in the biochemically
determined GAG/DNA could be established (Fig. 3B). The
variations observed among aggregates might be due to the
fact that they were formed by distinct sub-populations of
chondrocytes present within native cartilage (Barbero et
Figure 3. Redifferentiation of human articular chondrocytes (HAC) cultured as monolayer or aggregates in
pellets. (A) Safranin O staining of representative pellets generated by HAC cultured as monolayer (I and III) or
aggregates (II and IV) after two weeks’ culture in chondrogenic medium. Bars = 100 μm. (B) Sulphated
glycosaminoglycan (GAG) content, normalized to the DNA content, of the pellets generated by HAC expanded as
monolayer or aggregates after two weeks’ culture in chondrogenic medium.
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Figure 4. Redifferentiation of human articular chondrocytes (HAC) derived from donor 3 (71 y) or donor 4
(18 y) seeded as monolayer or aggregates within a scaffold. (A-B) Distribution of HAC thought the Hyaff®-11
non-woven meshes following 24 hours perfusion seeding of cells cultured as monolayer (I) or aggregates (II). (C-
D) Safranin O staining of representative constructs generated by HAC cultured as monolayer (I) or aggregates (II)
after two weeks’ culture in chondrogenic medium. Bars = 100 μm. (E-F) Sulphated glycosaminoglycan (GAG)
content of the resulting tissues, reported as total amounts / scaffold (I) or after normalization to the DNA content
(II).
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al., 2003; Thornemo et al., 2005), or that they were at
different stages of development upon transfer into pellets.
Alternatively, since the number of chondrocytes per
aggregate could not be controlled, the variability in the
chondrogenesis among aggregates might have resulted
from differences in their size, in turn affecting patterns of
nutrition and/or generation of oxygen gradients.
3D culture within scaffolds. HAC from donor 3 (71
years) were cultured in monolayer or aggregates for 3 days
in Phase 2 and then seeded within Hyaff®-11 meshes under
direct perfusion at a density of 4 millions of cells per
scaffold. The efficiency of seeding of both monolayer- or
aggregate-cultured chondrocytes, calculated by assessing
the DNA content of seeded constructs, was consistently
greater than 90%. After 4 weeks’ culture in chondrogenic
medium, cells expanded in monolayer remained
fibroblastic and the resulting tissues were only faintly
stained for GAG (Fig. 4C). In contrast, HAC cultured in
aggregates for 3 days had a more round morphology and
generated scattered areas of Safranin O-positive matrix.
Biochemical analyses confirmed a significantly higher
accumulation of GAG in scaffolds seeded with aggregate-
as compared to monolayer-cultured cells (Fig. 4E). The
overall limited extent of chondrogenesis, under similar
conditions previously reported to support cartilage tissue
formation, can be explained by the rather old age of the
donor (Barbero et al., 2004) and/or the low cell seeding
density used (Moretti et al., 2005) (Fig 4A). We thus
performed one additional experiment in which cells derived
from a younger donor (donor 4, 18 years) were seeded at
higher density in the scaffold (i.e.: 8 millions cells/scaffold)
as single cells (i.e.: cells cultured in monolayer) or
aggregates. Histological analysis of scaffolds after 24 hours
perfusion seeding confirmed that scaffolds seeded with
HAC from donor 4 were more cellular than those seeded
with HAC from donor 3 and indicated that, while single
cells were uniformly distributed through the scaffolds,
aggregates were mainly concentrated at the periphery (Fig
4A-B). Despite the generally higher extent of
chondrogenesis by cells from donor 4 in each culture
condition, the trend of improved deposition of GAG
following pre-aggregation was confirmed (Fig. 4D and F).
Enhancement of chondrogenesis following cell
aggregation may be explained by early upregulation of
cell-cell and cell-matrix adhesion molecules, which are
known to be key to initiate the chondrocyte differentiation
program during mesenchymal condensation (Tavella et al.,
1997). This interpretation would be consistent with a less
marked effect of HAC aggregation in the pellet culture
model, where the high cell density would already induce
upregulation of such molecules (DeLise et al., 2000). The
results are also consistent with the findings of Masuda et
al. (2003) that a first step of chondrocyte culture in alginate
induces the production of a proteoglycan-rich cell
associated matrix (CM) and the formation of cartilaginous
structures following culture of the recovered cells and CM
from the beads within a porous membrane. Preferential
chondrogenesis at the periphery of the aggregate-seeded
scaffolds could be explained by an initially higher cell
density in the outer region of the constructs, which in turn
could result from a limited penetration of the aggregates
through the scaffold pores during seeding, and/or from
limited nutrition of cells in the interior regions. A higher
uniformity of the engineered cartilage grafts could thus
be obtained by (i) standardizing the size and shape of the
aggregates into a suitable range (e.g., by using hanging
drop methods (Kelm et al., 2003; Del Duca et al., 2004)),
(ii) using scaffolds with a more open pore structure (e.g.,
rapid-prototyped structures with grid shapes (Woodfield
et al., 2004)), and/or (iii) increasing mass transport through
the constructs (e.g., continuing the perfusion regime
following cell seeding (Wendt et al., 2006)).
Conclusions
We have shown that even in the presence of strong
chondrocyte mitogens, HAC in aggregate cultures undergo
a limited extent of growth, but their dedifferentiation is
strongly reduced as compared to cells expanded in
monolayer for the same time. Aggregation of HAC prior
to perfusion-seeding into porous scaffolds enhanced
chondrogenesis and allowed generation of cartilage tissues
with increased GAG contents. Our study provides a proof-
of-principle that HAC expansion in monolayer combined
with a subsequent short culture phase in aggregate prior
to seeding into a scaffold could be a valid strategy to
engineer cartilage grafts starting from the limited number
of cells that can be isolated from a small biopsy.
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